12 Months Clinical Follow-up of Non-Carious Cervical Lesions Restored With New Injectable Composite

Sponsor
Yuzuncu Yıl University (Other)
Overall Status
Completed
CT.gov ID
NCT04095520
Collaborator
(none)
27
1
2
28.8
0.9

Study Details

Study Description

Brief Summary

Non-carious cervical lesions are defined as loss of pathological material not associated with caries in the enamel-cement junction of the tooth. The etiology of these lesions has been defined as brush abrasion, acid-induced erosion and abstraction due to microstructure losses due to stress concentration in a particular region of the tooth. These lesions should be restored using minimally invasive techniques. The necessity of restorative treatment is directly related to the size of the lesion, sensitivity and aesthetic requirements. However, restorative procedures are often challenging because the cavity preparation does not provide adequate retention, and often the cervical end margin is positioned under the gingiva. This leads to contamination of the operation site with blood, saliva and gingival fluid.

Several restorative options have been proposed for the treatment of cervical caries-free lesions. However, due to their high aesthetic properties, improved adhesive capacity and mechanical properties, composites have been accepted as the most suitable choice. Clinical studies have demonstrated that marginal adaptation, marginal discoloration, and roughening methods for retention are the most important factors in the clinical performances of composite restorations in cervical lesions. Therefore, injectable composites with wettability and better adaptability to cavity margins have been introduced. However, the low filler contents of fluid composites and their weak mechanical properties compared to conventional composites have led researchers to doubt their use in caries-free cervical lesions. As a result of the developed material technology, injectable composites with high filler which have reduced polymerization shrinkage have been developed with simplified filler procedure. However, investigators have not encountered any studies investigating which etching technique this material will exhibit better clinical performance and comparing it with traditional pasty composites. The aim of this study is to evaluate the clinical performance of traditional paste type and injectable composites which will be made by using two different etching techniques.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laser Etching
  • Procedure: Phosphoric acid etching
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
27 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Non-Carious Cervical Lesions Restored With Different Etching Methods and New Injectable Composite: One Year Clinical Follow-Up
Actual Study Start Date :
Sep 1, 2019
Actual Primary Completion Date :
Jan 25, 2022
Actual Study Completion Date :
Jan 25, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Paste Type Traditional Composite-GC G Aenial Anterior

Non-carious cervical lesions with shallow depth of less than 3 mm will be restored with microhybrid composite

Procedure: Laser Etching
Before the restorations, cavities will be etched Er:Cr YSGG laser with 4W output power, water pressure 95% and air pressure 60% with MGG6 tip with the spot size of 600 µm will be used.

Procedure: Phosphoric acid etching
Before the restorations, cavities will be etched with %37 phosphoric acid for 15 seconds.

Experimental: Injectable Composite- GC G Aenial Universal Injectable

Non-carious cervical lesions with shallow depth of less than 3 mm will be restored with injectable form composite

Procedure: Laser Etching
Before the restorations, cavities will be etched Er:Cr YSGG laser with 4W output power, water pressure 95% and air pressure 60% with MGG6 tip with the spot size of 600 µm will be used.

Procedure: Phosphoric acid etching
Before the restorations, cavities will be etched with %37 phosphoric acid for 15 seconds.

Outcome Measures

Primary Outcome Measures

  1. Evaluation the Changes of Surface Luster [1st day, 1st week,6th month, 1st year]

    Surface luster of the restorations will be evaluated and scored according to the FDI Direct Restorations Clinical Criteria Scale.

  2. Evaluation the Changes of Retention [1st day, 1st week,6th month, 1st year]

    Fractures and retention of the restorations will be evaluated and scored according to the FDI Direct Restorations Clinical Criteria Scale.

  3. Evaluation the Changes of Surface Staining [1st day, 1st week,6th month, 1st year]

    Surface staining of the restorations will be evaluated and scored according to the FDI Direct Restorations Clinical Criteria Scale.

  4. Evaluation the Changes of Color Stability and Translucency [1st day, 1st week, 6th month, 1st year]

    Color Stability and translucency of the restorations will be evaluated and scored according to the FDI Direct Restorations Clinical Criteria Scale.

  5. Evaluation the Changes of Anatomic Form [1st day, 1st week, 6th month, 1st year]

    Anatomic form of the restorations will be evaluated and scored according to the FDI Direct Restorations Clinical Criteria Scale.

  6. Evaluation the Changes of Marginal Adaptation [1st day, 1st week, 6th month, 1st year]

    Marginal adaptation of the restorations will be evaluated and scored according to the FDI Direct Restorations Clinical Criteria Scale.

  7. Evaluation the Changes of Wear [1st day, 1st week, 6th month, 1st year]

    Wear of the restorations will be evaluated and scored according to the FDI Direct Restorations Clinical Criteria Scale.

  8. Evaluation the Changes of Patients View [1st day, 1st week, 6th month, 1st year]

    Patients view of the restorations will be evaluated and scored according to the FDI Direct Restorations Clinical Criteria Scale.

  9. Evaluation the Changes of Postoperative (hyper-)sensitivity and tooth vitality [1st day, 1st week, 6th month, 1st year]

    Postoperative (hyper-)sensitivity and tooth vitality of the restorations will be evaluated and scored according to the FDI Direct Restorations Clinical Criteria Scale.

  10. Evaluation the Changes of Recurrence of Caries, Erosion, Abfraction [1st day, 1st week, 6th month, 1st year]

    Recurrence of Caries, Erosion, Abfraction of the restorations will be evaluated and scored according to the FDI Direct Restorations Clinical Criteria Scale.

  11. Evaluation the Changes of Tooth integrity [1st day, 1st week, 6th month, 1st year]

    Tooth integrity of the restorations will be evaluated and scored according to the FDI Direct Restorations Clinical Criteria Scale.

  12. Evaluation the Changes of Periodontal response [1st day, 1st week, 6th month, 1st year]

    Periodontal response of the restorations will be evaluated and scored according to the FDI Direct Restorations Clinical Criteria Scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients with cervical lesions in the mouth with multiples of 4 and 4,

  • Patients over 18 years of age and in permanent dentition,

  • Patients who do not have a pulpal or endodontic lesion on their teeth to be treated,

  • Patients without sensitivity to percussion in the teeth to be treated.

Exclusion Criteria:

Patients with any systemic disease,

  • Pregnant or suspected pregnancy and also breastfeeding patients,

  • Patients who are allergic to any dental material,

  • Patients with any periodontal disease,

  • Patients with poor oral hygiene,

  • In cases where the teeth are exposed to excessive load due to excessive rupture,

  • Cervical caries lesions,

  • Patients who continue orthodontic treatment,

  • Desensitizing agents or fluoride treatment.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Van Yuzuncu Yil University, Faculty of Dentistry Van Turkey 65100

Sponsors and Collaborators

  • Yuzuncu Yıl University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alperen Degirmenci, Assistant Professor, Yuzuncu Yıl University
ClinicalTrials.gov Identifier:
NCT04095520
Other Study ID Numbers:
  • 15/ 06.08.2019
First Posted:
Sep 19, 2019
Last Update Posted:
Feb 18, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 18, 2022